PBPX: Penicillin-binding protein 2x
Protein in Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) that 1 drug acts on.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on PBPX, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Ceftaroline fosamil | Approved | AbbVie | Small molecule | InhibitorPenicillin-binding protein 2x inhibitor | 5 |
| Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia | Ceftaroline fosamil | Phase 4 | Recruiting | Intermountain Health Care, Inc. | Jan 29, 2026 |
| Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection | Ceftaroline fosamil | Phase 1 | Enrolling by invitation | Vancouver Coastal Health | Nov 14, 2025 |
| Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes? | Ceftaroline fosamil | Phase 4 | Enrolling by invitation | West Virginia University | Aug 29, 2025 |
| Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) | Ceftaroline fosamil | Phase 3 | Active, not recruiting | Hellenic Institute for the Study of Sepsis | Mar 5, 2024 |
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | Ceftaroline fosamil | Phase 3 | Recruiting | UMC Utrecht | Apr 13, 2016 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL6188, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets